Alan L Crane - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Alan L Crane made no insider transaction in Vaccinex Inc (). Other recent insider transactions involving Vaccinex Inc () include a net purchase of 3,000,282 shares made by Albert Friedberg , a net sale of 4,483 shares made by Van Strydonck, Gerald E. , and a net purchase of 510,000 shares made by Maurice Zauderer .

In summary, during the past 3 months, insiders sold 0 shares of Vaccinex Inc () in total and bought 282 shares, with a net purchase of 282 shares. During the past 18 months, 320 shares of Vaccinex Inc () were sold and 250,996 shares were bought by its insiders, resulting in a net purchase of 250,676 shares.

Vaccinex Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dare Bioscience Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dare Bioscience Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dare Bioscience Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Alan L Crane made no insider transaction in T2 Biosystems Inc (). Other recent insider transactions involving T2 Biosystems Inc () include a net sale of 48,345,798 shares made by Cr Group L.p. , a net sale of 2,366 shares made by Brett A. Giffin , and a net sale of 3,969 shares made by Michael Terrence Gibbs .

In summary, during the past 3 months, insiders sold 0 shares of T2 Biosystems Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 48,364,599 shares of T2 Biosystems Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 48,364,599 shares.

T2 Biosystems Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Alan L Crane made no insider transaction in Ocular Therapeutix Inc (). Other recent insider transactions involving Ocular Therapeutix Inc () include a net sale of 51,149 shares made by Antony C. Mattessich , a net sale of 21,358 shares made by Rabia Gurses Ozden , and a net purchase of 2,476,640 shares made by Summer Road Llc .

In summary, during the past 3 months, insiders sold 88,652 shares of Ocular Therapeutix Inc () in total and bought 930,851 shares, with a net purchase of 842,199 shares. During the past 18 months, 134,055 shares of Ocular Therapeutix Inc () were sold and 2,483,140 shares were bought by its insiders, resulting in a net purchase of 2,349,085 shares.

Ocular Therapeutix Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Momenta Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Momenta Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Momenta Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.